- Article
Targeted Biological Therapy and Germline Mutation Prevalence in Advanced Ovarian Cancer Patients
- Anne-Marie Mosbæk Ellegaard,
- Tim Svenstrup Poulsen and
- Estrid Høgdall
Background: Ovarian cancer is one of the most lethal gynecological malignancies, often diagnosed at an advanced stage. The prognosis is generally poor, with high recurrence rates and limited long-term survival. Understanding the genetic and molecular...

